These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 9276728
1. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG. J Clin Invest; 1997 Sep 01; 100(5):1114-22. PubMed ID: 9276728 [Abstract] [Full Text] [Related]
2. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, Pyrdol J, Ditzel H, Raine C, Engberg J, Fugger L. J Exp Med; 2000 Apr 17; 191(8):1395-412. PubMed ID: 10770805 [Abstract] [Full Text] [Related]
7. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L, Beck H, McFarland HF, De Mars R, Long EO, Martin R. J Neuroimmunol; 1997 Aug 17; 77(2):195-203. PubMed ID: 9258250 [Abstract] [Full Text] [Related]
8. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. Fridkis-Hareli M, Santambrogio L, Stern JN, Fugger L, Brosnan C, Strominger JL. J Clin Invest; 2002 Jun 17; 109(12):1635-43. PubMed ID: 12070311 [Abstract] [Full Text] [Related]
11. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Gauthier L, Smith KJ, Pyrdol J, Kalandadze A, Strominger JL, Wiley DC, Wucherpfennig KW. Proc Natl Acad Sci U S A; 1998 Sep 29; 95(20):11828-33. PubMed ID: 9751750 [Abstract] [Full Text] [Related]
12. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses. Fridkis-Hareli M, Stern JN, Fugger L, Strominger JL. Hum Immunol; 2001 Aug 29; 62(8):753-63. PubMed ID: 11476898 [Abstract] [Full Text] [Related]
20. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Salvetti M, Ristori G, D'Amato M, Buttinelli C, Falcone M, Fieschi C, Wekerle H, Pozzilli C. Eur J Immunol; 1993 Jun 06; 23(6):1232-9. PubMed ID: 7684682 [Abstract] [Full Text] [Related] Page: [Next] [New Search]